Subscribe
Sign in
Home
Archive
About
Latest
Top
AI is Not a Fad
Ubiquitous AI and its Impact on the Real World
Aug 12
•
James Wang
and
Kulika Weizman
15
April 2025
Biodata Lessons from the Rise and Fall of 23andMe
An expensive case study in why business models matter for biodata companies
Apr 7
•
Kulika Weizman
and
James Wang
February 2025
We're all Special Situations Funds Now
Observing (and marking) venture portfolios honestly—and an analogy to Japan's Lost Decades
Feb 21
•
James Wang
and
Kulika Weizman
January 2025
Why Biodata and The Secrets of 100-Year-Olds
Exploring our biodata investment thesis with the centenarian biobank as a case study.
Jan 7
•
Kulika Weizman
and
James Wang
December 2024
New Year, New Newsletter
Updates about Creative Ventures and our New Thesis
Dec 9, 2024
•
James Wang
and
Kulika Weizman
January 2024
January 2024 portfolio round-up
News from Our Companies
Jan 31, 2024
•
Champ Suthipongchai
December 2023
Why We Invested in Tierra Biosciences
Revolutionary Protein Synthesis and AI Platforms
Dec 20, 2023
•
Kulika Weizman
November 2023
Creative Conversations: Meet Champ Suthipongchai
Interviews with Folks at Creative Ventures
Nov 15, 2023
•
Champ Suthipongchai
October 2023
October 2023 Portfolio News
Exciting Progress, Even in a Tough Environment
Oct 31, 2023
•
Champ Suthipongchai
Is the robotics revolution upon us?
Opportunities for Change
Oct 27, 2023
•
AL
Meet Our Mavens: Christy Sheehy-Bensinger
Research Scientist Turned Entrepreneur
Oct 26, 2023
•
Champ Suthipongchai
Kulika Weizman is Newest General Partner at Creative Ventures
Growing Our Team for a Deep Tech Future
Oct 16, 2023
•
Champ Suthipongchai
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts